Neurological Biomarkers Market Size Was Valued at USD 9.40 Billion in 2023, and is Projected to Reach USD 28.97 Billion by 2032, Growing at a CAGR of 13% From 2024-2032. Neurological biomarkers are bio-active markers that may be detected in the brain, blood or cereal fluid to establish diagnosis of neurological disorders including Alzhiemers disease, Parkinson’s disease, Multiple s... https://introspectivemarketresearch.com/reports/neurological-biomarkers-market/